ArticleDigital health
Enhancing diabetic retinopathy classification using deep learning.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 10 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
- Retracted
- Retracted
Authors and funding
4 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prolonged hyperglycemia can cause diabetic retinopathy (DR), which is a major contributor to blindness. Numerous incidences of DR may be avoided if it were identified and addressed promptly. Throughout recent years, many deep learning (DL)-based algorithms have been proposed to facilitate psychometric testing. Utilizing DL model that encompassed four scenarios, DR and its stages were identified in this study using retinal scans from the "Asia Pacific Tele-Ophthalmology Society (APTOS) 2019 Blindness Detection" dataset. Adopting a DL model then led to the use of augmentation strategies that produced a comprehensive dataset with consistent hyper parameters across all test cases. As a further step in the classification process, we used a Convolutional Neural Network model. Different enhancement methods have been used to raise visual quality. The proposed approach detected the DR with a highest experimental result of 97.83%, a top-2 accuracy of 99.31%, and a top-3 accuracy of 99.88% across all the 5 severity stages of the APTOS 2019 evaluation employing CLAHE and ESRGAN techniques for image enhancement. In addition, we employed APTOS 2019 to develop a set of evaluation metrics (precision, recall, and F1-score) to use in analyzing the efficacy of the suggested model. The proposed approach was also proven to be more efficient at DR location than both state-of-the-art technology and conventional DL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.